NEW YORK (GenomeWeb) – PositiveID announced today that it has formed a new subsidiary called ExcitePCR for the purposes of fully developing its Firefly Dx real-time PCR breadboard prototype pathogen detection system.

ExcitePCR, which is wholly owned by PositiveID, will own Firefly Dx. This arrangement allows for greater strategic flexibility, enabling the company to better pursue development partnerships or financing opportunities, PositiveID said.